Search bioRxiv⌕ Search

Biology subjects

Brengel-Pesce, K.

Publications and source records attributed to Brengel-Pesce, K..

4 recordsLinked to original sources

Stoichiometric Encoding of Amplification Kinetics Enables High-Level Multiplexing in Single-Channel TaqMan Real-Time PCR

Multiplexing in TaqMan real-time PCR (qPCR) is limited to four-six targets per reaction by fluorophore spectral overlap. Amplification curve analysis (ACA) can discriminate several targets within one fluorescence channel from amplification curves (AC) kinetic features, but has been confined mainly to digital qPCR (dqPCR) and is sensitive to domain shifts between instruments and specimen types. Here, we co-design biochemical encoding of target-specific information into ACs and their computational decoding to achieve single-channel 8-plex TaqMan qPCR on a standard thermocycler. Using asymmetric PCR, we show that forward primer, reverse primer and probe concentrations act as a programmable encoding mechanism, generating a 27-condition design space of reproducible non-canonical ACs, conserved from digital to bulk qPCR. Applying this stoichiometric encoding to an 8-plex central nervous system pathogens panel increased inter-target separability, raising the mean silhouette score from 0.329 to 0.711. To decode ACs without labelled target-domain bulk qPCR data, we pretrained a transformer encoder by self-supervised learning on more than 170,000 unlabelled dqPCR curves and aligned source and target domains using conditional domain adversarial training. On contrived clinical specimens, the framework classified a canonical 7-plex respiratory virus panel with 83.6% accuracy (versus 67.7% for a supervised baseline) and the encoded 8-plex panel with 89.8% accuracy. Furthermore, stoichiometric encoding enabled resolution of double- and triple-target co-amplification events with 98.7% accuracy in controlled dqPCR experiments. This approach expands the information capacity of existing qPCR instrumentation without new hardware, fluorophores or oligonucleotides, offering a low-cost route to syndromic molecular diagnostics.

molecular biology↗

Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)

We present the first genetic characterization of a COVID-19 cluster in Europe using metagenomic next-generation sequencing (mNGS). Despite low viral loads, the mNGS workflow used herein allowed to characterize the whole genome sequences of SARS-CoV2 isolated from an asymptomatic patient, in 2 clinical samples collected 1 day apart. Comparison of these sequences suggests viral evolution with development of quasispecies. In addition, the present workflow identified a new deletion in nsp2 (Asp268Del) which was found in all 3 samples originating from this cluster as well as in 37 other viruses collected in England and in Netherlands, suggesting the spread of this deletion in Europe. The impact of Asp268Del on SARS-CoV-2 transmission and pathogenicity, as well as on PCR performances and anti-viral strategy should be rapidly evaluated in further studies.

microbiology↗

Towards standardization of immune functional assays

Recent advances in the immunotherapy field require evaluation of the immune function to adapt therapeutic decisions. Immune functional assays (IFA) are able to reveal the immune status and would be useful to further adapt/improve patients care. However, standardized methods are needed to implement IFA in clinical settings. We carried out an independent validation of a published method used to characterize the underlying host response to infectious conditions using an IFA. We evaluate the reproducibility and robustness of this IFA and associated readout using an independent healthy volunteers (HV) cohort. Expression of a 44 genes-signatures and IFN{gamma} protein secretion and gene-expression was assessed after stimulation. We observed a strong host-response correlation between the two cohorts. We also highlight that standardized methods for immune function evaluation exist and could be implemented in larger-scale studies. This IFA could be a relevant tool to reveal innate/adaptive immune dysfunction in immune-related disorders patients.

immunology↗

Immune Profiling Panel: a proof of concept study of a new multiplex molecular tool to assess the immune status of critically-ill patients

BackgroundCritical illness such as sepsis is a life-threatening syndrome defined as a dysregulated host response to infection and is characterized by patients exhibiting various impaired immune profiles. In the field of diagnosis, a gap still remains in identifying the immune profile of critically-ill patients in the ICU. The availability of an immune profiling tool holds a great potential in providing patients at high risk with more accurate and precise management. In this study, a multiplex immune profiling panel prototype was assessed for its ability to semi-quantify immune markers directly from blood, using the FilmArray(R) System.\n\nResultsThe Immune Profiling Panel (IPP) prototype consists of 16 biomarkers that target both the innate and adaptive immune responses, pro- and anti-inflammatory mediators as well as genes involved in diverse regulatory pathways. The analytical studies carried out on healthy volunteers showed minimal inter- and intra-variability in testing the samples across the tested lots. The majority of the assays were linear with an R2 higher than 0.8. Results from the IPP pouch were comparable to qPCR and were within the limits of agreement. Finally, quantification cycle values of the target genes were normalized against reference genes to account for the different composition of cells among specimens. The use of the selected panel of markers in IPP demonstrated various gene modulations that could distinctly differentiate three profiles: healthy, borderline mHLA-DR septic shock patients and low mHLA-DR septic shock patients.\n\nConclusionThe Immune Profiling Panel allowed host transcriptomic analysis of immune response biomarkers directly from whole blood in less than an hour. The use of IPP showed great potential for the development of a fully automated, rapid and easy-to-use immune profiling tool, enabling the stratification of critically-ill patients at high risk in the ICU.

immunology↗